[Oxytetracycline in the milk of dairy cows with clinical signs of mastitis during the lactation period].
The objective of this study was to determine the oxytetracycline residues in milk from cows with clinical mastitis dosed with two extra-label routes of oxytetracycline administration not only during antibiotic's treatment (5 days), but also six days after treatment by use of a liquid chromatography method of testing with a detection limit of 20 ppb. Both groups of animals were treated once daily for five milkings at 24-hour intervals following morning milkings. Composite milk samples (equal volumes of foremilk from each quarter) were collected during morning and afternoon milkings, mixed together (1:1), and stored until analyzed. Milk samples were analyzed just before the first treatment (0 hour) and ten times at 24-hour intervals. Residue studies in milk cows indicate that oxytetracycline passes into milk. Residues in milk were higher for the cows receiving oxytetracycline by intramammary route (Tab. I) than for the cows receiving oxytetracycline intramuscularly (Tab. II). The highest mean data were 195.68 mg/kg after intramammary infusion (Fig. 2) and 2.74 mg/kg after intramuscular injection (Fig. 3) on the 5th day of the treatment beginning. The analysis data showed that oxytetracycline persisted in milk for as long as two days after both treatments at the concentration 0.03 mg/kg versus 0.02 mg/kg, respectively. No residues were detected in milk of any animal from the 4th day of the cessation of the therapy (Fig. 1) as detected by the HPLC method.
Dudriková
E
E
University of Veterinary Medicine, Kosice, Slovak Republic.
Sokol
J
J
Burdová
O
O
Turek
P
P
Cabadaj
R
R
D000818:Animals; D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000627:therapeutic use; D002417:Cattle; D004350:Drug Residues / Q000032:analysis*; D005260:Female; D007774:Lactation / Q000378:metabolism*; D008414:Mastitis, Bovine / Q000188:drug therapy* / Q000378:metabolism; D008892:Milk / Q000737:chemistry*; D010118:Oxytetracycline / Q000032:analysis* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010118:Oxytetracycline